Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors

酶动力学 自磷酸化 突变体 激酶 受体酪氨酸激酶 生物化学 化学 背景(考古学) 酪氨酸激酶 生物 分子生物学 受体 活动站点 蛋白激酶A 基因 古生物学
作者
Sergei Timofeevski,Michele McTigue,Kevin Ryan,Jean Cui,Helen Y. Zou,Jeff Zhu,Fannie Chau,Gordon Alton,Shannon Karlicek,James G. Christensen,Brion W. Murray
出处
期刊:Biochemistry [American Chemical Society]
卷期号:48 (23): 5339-5349 被引量:95
标识
DOI:10.1021/bi900438w
摘要

The c-Met receptor tyrosine kinase (RTK) is a key regulator in cancer, in part, through oncogenic mutations. Eight clinically relevant mutants were characterized by biochemical, biophysical, and cellular methods. The c-Met catalytic domain was highly active in the unphosphorylated state (kcat = 1.0 s−1) and achieved 160-fold enhanced catalytic efficiency (kcat/Km) upon activation to 425000 s−1 M−1. c-Met mutants had 2−10-fold higher basal enzymatic activity (kcat) but achieved maximal activities similar to those of wild-type c-Met, except for Y1235D, which underwent a reduction in maximal activity. Small enhancements of basal activity were shown to have profound effects on the acquisition of full enzymatic activity achieved through accelerating rates of autophosphorylation. Biophysical analysis of c-Met mutants revealed minimal melting temperature differences indicating that the mutations did not alter protein stability. A model of RTK activation is proposed to describe how a RTK response may be matched to a biological context through enzymatic properties. Two c-Met clinical candidates from aminopyridine and triazolopyrazine chemical series (PF-02341066 and PF-04217903) were studied. Biochemically, each series produced molecules that are highly selective against a large panel of kinases, with PF-04217903 (>1000-fold selective relative to 208 kinases) being more selective than PF-02341066. Although these prototype inhibitors have similar potencies against wild-type c-Met (Ki = 6−7 nM), significant differences in potency were observed for clinically relevant mutations evaluated in both biochemical and cellular contexts. In particular, PF-02341066 was 180-fold more active against the Y1230C mutant c-Met than PF-04217903. These highly optimized inhibitors indicate that for kinases susceptible to active site mutations, inhibitor design may need to balance overall kinase selectivity with the ability to inhibit multiple mutant forms of the kinase (penetrance).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美世界应助南瓜气气采纳,获得10
1秒前
1秒前
深情安青应助稳重向南采纳,获得10
1秒前
2秒前
wuzhizhongbin完成签到,获得积分10
2秒前
Lucas应助fksci采纳,获得10
3秒前
4秒前
4秒前
5秒前
5秒前
Hello应助哈哈哈采纳,获得10
5秒前
5秒前
5秒前
6秒前
研友_VZG7GZ应助火星上友易采纳,获得10
6秒前
平常的可乐完成签到 ,获得积分10
6秒前
小黄鸭发布了新的文献求助10
7秒前
7秒前
零几年完成签到,获得积分10
7秒前
szh123发布了新的文献求助10
8秒前
上官若男应助肖剑采纳,获得10
8秒前
8秒前
CodeCraft应助应夏山采纳,获得10
9秒前
领导范儿应助mm_zxh采纳,获得10
9秒前
9秒前
受伤幻桃发布了新的文献求助10
10秒前
Fran07发布了新的文献求助10
10秒前
1231发布了新的文献求助10
11秒前
hanlanx发布了新的文献求助10
11秒前
小二郎应助稳重向南采纳,获得10
11秒前
快乐难敌发布了新的文献求助10
11秒前
michi发布了新的文献求助10
11秒前
13秒前
whisper发布了新的文献求助10
13秒前
鱼咬羊发布了新的文献求助10
13秒前
birb发布了新的文献求助10
14秒前
14秒前
kkxl完成签到 ,获得积分10
14秒前
小蘑菇应助伱相信光马采纳,获得10
14秒前
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971395
求助须知:如何正确求助?哪些是违规求助? 3516110
关于积分的说明 11180848
捐赠科研通 3251238
什么是DOI,文献DOI怎么找? 1795760
邀请新用户注册赠送积分活动 876012
科研通“疑难数据库(出版商)”最低求助积分说明 805228